Performance of a fourth-generation HIV screening assay and an alternative HIV diagnostic testing algorithm
被引:38
|
作者:
Nasrullah, Muazzam
论文数: 0引用数: 0
h-index: 0
机构:
Ctr Dis Control & Prevent CDC, Div HIV AIDS Prevent, Natl Ctr HIV Hepatitis STD & TB Prevent, Atlanta, GA USACtr Dis Control & Prevent CDC, Div HIV AIDS Prevent, Natl Ctr HIV Hepatitis STD & TB Prevent, Atlanta, GA USA
Nasrullah, Muazzam
[1
]
Wesolowski, Laura G.
论文数: 0引用数: 0
h-index: 0
机构:
Ctr Dis Control & Prevent CDC, Div HIV AIDS Prevent, Natl Ctr HIV Hepatitis STD & TB Prevent, Atlanta, GA USACtr Dis Control & Prevent CDC, Div HIV AIDS Prevent, Natl Ctr HIV Hepatitis STD & TB Prevent, Atlanta, GA USA
Wesolowski, Laura G.
[1
]
Meyer, William A., III
论文数: 0引用数: 0
h-index: 0
机构:
Quest Diagnost, Baltimore, MD USACtr Dis Control & Prevent CDC, Div HIV AIDS Prevent, Natl Ctr HIV Hepatitis STD & TB Prevent, Atlanta, GA USA
Meyer, William A., III
[2
]
Owen, S. Michele
论文数: 0引用数: 0
h-index: 0
机构:
Ctr Dis Control & Prevent CDC, Div HIV AIDS Prevent, Natl Ctr HIV Hepatitis STD & TB Prevent, Atlanta, GA USACtr Dis Control & Prevent CDC, Div HIV AIDS Prevent, Natl Ctr HIV Hepatitis STD & TB Prevent, Atlanta, GA USA
Owen, S. Michele
[1
]
Masciotra, Silvina
论文数: 0引用数: 0
h-index: 0
机构:
Ctr Dis Control & Prevent CDC, Div HIV AIDS Prevent, Natl Ctr HIV Hepatitis STD & TB Prevent, Atlanta, GA USACtr Dis Control & Prevent CDC, Div HIV AIDS Prevent, Natl Ctr HIV Hepatitis STD & TB Prevent, Atlanta, GA USA
Masciotra, Silvina
[1
]
Vorwald, Craig
论文数: 0引用数: 0
h-index: 0
机构:
Quest Diagnost, Collegeville, PA USACtr Dis Control & Prevent CDC, Div HIV AIDS Prevent, Natl Ctr HIV Hepatitis STD & TB Prevent, Atlanta, GA USA
Vorwald, Craig
[3
]
Becker, William J.
论文数: 0引用数: 0
h-index: 0
机构:
Quest Diagnost, Lenexa, KS USACtr Dis Control & Prevent CDC, Div HIV AIDS Prevent, Natl Ctr HIV Hepatitis STD & TB Prevent, Atlanta, GA USA
Becker, William J.
[4
]
Branson, Bernard M.
论文数: 0引用数: 0
h-index: 0
机构:
Ctr Dis Control & Prevent CDC, Div HIV AIDS Prevent, Natl Ctr HIV Hepatitis STD & TB Prevent, Atlanta, GA USACtr Dis Control & Prevent CDC, Div HIV AIDS Prevent, Natl Ctr HIV Hepatitis STD & TB Prevent, Atlanta, GA USA
Branson, Bernard M.
[1
]
机构:
[1] Ctr Dis Control & Prevent CDC, Div HIV AIDS Prevent, Natl Ctr HIV Hepatitis STD & TB Prevent, Atlanta, GA USA
Objective: We evaluated the performance of the GS fourth-generation antigen/antibody assay and compared Centers for Disease Control and Prevention's (CDC's) proposed alternative algorithm [repeatedly reactive fourth-generation immunoassay followed by an HIV-1/HIV-2 differentiation immunoassay and, if needed, nucleic acid test (NAT)] with the current algorithm (repeatedly reactive third-generation immunoassay followed by HIV-1 western blot). Design: A convenience sample of the following four specimen sets was acquired: 10 014 from insurance applicants, 493 known western blot-positive, 20 known western blot-indeterminate specimens, and 230 specimens from 26 HIV-1 seroconverters. Methods: Specimens were tested with the GS third-generation and fourth-generation immunoassays, the Multispot HIV-1/HIV-2 differentiation immunoassay, NAT, and western blot. We applied the two algorithms using these results. Results: Among insurance specimens, 13 (0.13%) specimens were immunoassay repeatedly reactive: two were HIV-positive (repeatedly reactive by third-generation and fourth-generation immunoassays, and western blot and Multispot positive); two third-generation repeatedly reactive and nine fourth-generation repeatedly reactive specimens were false-positive. Third-generation and fourth-generation specificities were 99.98% [95% confidence interval (CI) 99.93-100%] and 99.91% (95% CI 99.84-99.96%), respectively. All HIV-1 western blot-positive specimens were repeatedly reactive by third-generation and fourth-generation immunoassays. By Multispot, 491 (99.6%) were HIV-1-positive and two (0.4%) were HIV-2-positive. Only eight (40%) western blot-indeterminate specimens were fourth-generation repeatedly reactive: six were Multispot and NAT-negative and two were Multispot HIV-1-positive but NAT-negative. The alternative algorithm correctly classified as positive 102 seroconverter specimens with the third-generation immunoassay and 130 with the fourth-generation immunoassay compared with 56 using the western blot with either immunoassay. Conclusion: The alternative testing algorithm improved early infection sensitivity and identified HIV-2 infections. Two potential false-positive algorithm results occurred with western blot-indeterminate specimens. (C) 2013 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins AIDS 2013, 27:731-737